Chemotherapy and its evolving role in the management of advanced prostate cancer

por Schweizer, Michael T, Antonarakis, Emmanuel S
Publicado 2014

Persistent androgen receptor addiction in castration-resistant prostate cancer

por Schweizer, Michael T., Yu, Evan Y.
Publicado 2015

AR-Signaling in Human Malignancies: Prostate Cancer and Beyond

por Schweizer, Michael T., Yu, Evan Y.
Publicado 2017

Contribution of Model Organisms to Investigating the Far-Reaching Consequences of PRPP Metabolism on Human Health and Well-Being

por Ugbogu, Eziuche A., Schweizer, Lilian M., Schweizer, Michael
Publicado 2022

Re-sensitization to pembrolizumab following PSMA-CD3 T-cell redirection therapy with JNJ-081 in a patient with mismatch repair-deficient metastatic castration-resistant prostate ca...

por Reed-Perino, Darien E, Lai, Michael, Yu, Evan Y, Schweizer, Michael T
Publicado 2023

Hormone levels following surgical and medical castration: defining optimal androgen suppression

por Schweizer, Michael T, Hancock, Michael L, Getzenberg, Robert H, Yu, Evan Y
Publicado 2018

Clinical Efficacy of Bipolar Androgen Therapy in Men with Metastatic Castration-Resistant Prostate Cancer and Combined Tumor-Suppressor Loss

por Markowski, Mark C., Wang, Hao, De Marzo, Angelo M., Schweizer, Michael T., Antonarakis, Emmanuel S., Denmeade, Samuel R.
Publicado 2022

Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions

por Mohammad, Osama S., Nyquist, Michael D., Schweizer, Michael T., Balk, Stephen P., Corey, Eva, Plymate, Stephen, Nelson, Peter S., Mostaghel, Elahe A.
Publicado 2017

Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies

por Graham, Laura S., Montgomery, Bruce, Cheng, Heather H., Yu, Evan Y., Nelson, Peter S., Pritchard, Colin, Erickson, Stephanie, Alva, Ajjai, Schweizer, Michael T.
Publicado 2020

Novel Anti-Infective Compounds from Marine Bacteria

por Rahman, Hafizur, Austin, Brian, Mitchell, Wilfrid J., Morris, Peter C., Jamieson, Derek J., Adams, David R., Spragg, Andrew Mearns, Schweizer, Michael
Publicado 2010

Pharmacodynamic study of Disulfiram in Men with Non-metastatic Recurrent Prostate Cancer

por Schweizer, Michael T., Lin, Jianqing, Blackford, Amanda, Bardia, Aditya, King, Serina, Armstrong, Andrew J., Rudek, Michelle A., Yegnasubramanian, Srinivasan, Carducci, Michael A.
Publicado 2013

A Retrospective Observational Analysis of Overall Survival with Sipuleucel-T in Medicare Beneficiaries Treated for Advanced Prostate Cancer

por McKay, Rana R., Hafron, Jason M., Ferro, Christine, Wilfehrt, Helen M., Fitch, Kate, Flanders, Scott C., Fabrizio, Michael D., Schweizer, Michael T.
Publicado 2020

Microsatellite instability in prostate cancer by PCR or next-generation sequencing

por Hempelmann, Jennifer A., Lockwood, Christina M., Konnick, Eric Q., Schweizer, Michael T., Antonarakis, Emmanuel S., Lotan, Tamara L., Montgomery, Bruce, Nelson, Peter S., Klemfuss, Nola, Salipante, Stephen J., Pritchard, Colin C.
Publicado 2018

Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancer

por Carlson, Alexander S., Acevedo, Rigo I., Lim, Daniel M., Gulati, Roman, Gawne, Agnes, Sokolova, Alexandra O., Cheng, Heather H., Nelson, Peter S., Montgomery, R. Bruce, Yu, Evan Y., Schweizer, Michael T.
Publicado 2020

Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing Interference

por Jensen, Kendal, Konnick, Eric Q., Schweizer, Michael T., Sokolova, Alexandra O., Grivas, Petros, Cheng, Heather H., Klemfuss, Nola M., Beightol, Mallory, Yu, Evan Y., Nelson, Peter S., Montgomery, Bruce, Pritchard, Colin C.
Publicado 2020

Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate

por Schweizer, Michael T., Cheng, Heather H., Tretiakova, Maria S., Vakar-Lopez, Funda, Klemfuss, Nola, Konnick, Eric Q., Mostaghel, Elahe A., Nelson, Peter S., Yu, Evan Y., Montgomery, Bruce, True, Lawrence D., Pritchard, Colin C.
Publicado 2016

A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer

por Schweizer, Michael T., Haugk, Kathleen, McKiernan, Jožefa S., Gulati, Roman, Cheng, Heather H., Maes, Jessica L., Dumpit, Ruth F., Nelson, Peter S., Montgomery, Bruce, McCune, Jeannine S., Plymate, Stephen R., Yu, Evan Y.
Publicado 2018

Correction: A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer

por Schweizer, Michael T., Haugk, Kathleen, McKiernan, Jožefa S., Gulati, Roman, Cheng, Heather H., Maes, Jessica L., Dumpit, Ruth F., Nelson, Peter S., Montgomery, Bruce, McCune, Jeannine S., Plymate, Stephen R., Yu, Evan Y.
Publicado 2018

Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer

por Cheng, Heather H., Sokolova, Alexandra O., Gulati, Roman, Bowen, Deborah, Knerr, Sarah A., Klemfuss, Nola, Grivas, Petros, Hsieh, Andrew, Lee, John K., Schweizer, Michael T., Yezefski, Todd, Zhou, Alicia, Yu, Evan Y., Nelson, Peter S., Montgomery, Bruce
Publicado 2023

A Phase I Study to Assess the Safety and Cancer‐Homing Ability of Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer

por Schweizer, Michael T., Wang, Hao, Bivalacqua, Trinity J., Partin, Alan W., Lim, Su Jin, Chapman, Carolyn, Abdallah, Rehab, Levy, Oren, Bhowmick, Neil A., Karp, Jeffrey M., De Marzo, Angelo, Isaacs, John T., Brennen, W. Nathaniel, Denmeade, Samuel R.
Publicado 2019